Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-06

Clinical Trial Update: Bariatric Surgery and Pharmacokinetics of Apixaban

View source ↗

Summary

A clinical trial is evaluating how bariatric surgery affects the pharmacokinetics of the anticoagulant apixaban in individuals with obesity or morbid obesity, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eliquis (apixaban)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Obesity, Morbid | Status: RECRUITING